510(k) Report

510(k) · Cleared

Cleared

AI.ME System

K221011510(k) TraditionalCleared Dec 20, 2022259-day reviewClass II21 CFR 878.4430

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Venus Concept USA, Inc. · QAI Powered Microneedle Device

Cleared on Dec 20, 2022 as substantially equivalent to K202517 (Cytrellis Biosystems, Inc., 2021) after a 259-day review. Its family tree reaches back 3 generations to 2018.

Decided
Dec 20, 2022
Review
259 days
Class
Class II
Product code
QAI
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to DEN160029 (2018). No later device cites it as a predicate yet.

  1. Root · 3 generations backDEN160029 SkinPen Precision SystemBellus Medical, LLC · 2018
  2. 2 generations backK180778 Exceed Microneedling DeviceMt. Derm GmbH · 2018
  3. 1 generation backK202517 Cytrellis Dermal Micro-Coring SystemCytrellis Biosystems, Inc. · 2021 · Recalled
  4. This deviceK221011 AI.ME SystemVenus Concept USA, Inc. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3DEN160029SkinPen Precision SystemBellus Medical, LLC2018—
−2K180778Exceed Microneedling DeviceMt. Derm GmbH2018—
−1K202517Cytrellis Dermal Micro-Coring SystemCytrellis Biosystems, Inc.20212
0 (this device)K221011AI.ME SystemVenus Concept USA, Inc.2022—
FIG. 1 — Lineage of K221011, 2018–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QAI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QAI device

  1. #1 K230420 Dr. pen Microneedling Systemscore 14.8 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K202517Cytrellis Dermal Micro-Coring System
Summary page 4
…EVICES Device Name 510(k) Number Predicate Cytrellis Dermal Micro-Coring System (Ellacor) K202517 Reference #1 Fraxis DUO System K160312 Reference #2 ARTAS IX System…
Cytrellis Biosystems, Inc.20212
†K160312Fraxis DuoIlooda Co,., Ltd.2016—
†K173358ARTAS SystemRestoration Robotics, Inc.2018—

Also cleared against K202517: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 4 companies; a new generation was cleared every 1.4 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • 1 other device also cites its predicate K202517.

How does its category compare?

All QAI devices

QAI Powered Microneedle Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QAI

6in 2025

2018: 22019: 12020: 22021: 42022: 42023: 22024: 32025: 62026 (partial year): 2
2007high 6 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QAI

160in 2025

2021: 226 days median2022: 172 days median2024: 104 days median2025: 160 days median
2007high 226 (2021) · low 104 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QAI

1in 2019

2019: 1
2007high 1 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QAI

11in 2025

2020: 12021: 22022: 62023: 292024: 52025: 11
2007high 29 (2023) · low 0 (2007)2025

MAUDE reports naming product code QAI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20182—00
20191—10
20202—01
2021422602
2022417206
20232—029
2024310405
20256160011
20262—0—

What is it indicated for?

The AI.ME system is indicated for fractional skin resurfacing.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K221011: AI.ME System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K221011

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026